The Growing Role of Technology in the Care of Older Adults With Diabetes.

Document Type


Publication Date


Publication Title

Diabetes Care







First Page


Last Page



The integration of technologies such as continuous glucose monitors, insulin pumps, and smart pens into diabetes management has the potential to support the transformation of health care services that provide a higher quality of diabetes care, lower costs and administrative burdens, and greater empowerment for people with diabetes and their caregivers. Among people with diabetes, older adults are a distinct subpopulation in terms of their clinical heterogeneity, care priorities, and technology integration. The scientific evidence and clinical experience with these technologies among older adults are growing but are still modest. In this review, we describe the current knowledge regarding the impact of technology in older adults with diabetes, identify major barriers to the use of existing and emerging technologies, describe areas of care that could be optimized by technology, and identify areas for future research to fulfill the potential promise of evidence-based technology integrated into care for this important population.


Funding: The International Geriatric Diabetes Society gratefully acknowledges the support of Abbott Diabetes Care, Dexcom, Medtronic, and Sanofi and the unrestricted educational grant provided by Novo Nordisk, Inc., for the International Geriatric Diabetes Technology Workshop. Discussion and debate that took place at the workshop led to the development of the content for this manuscript. E.S.H. reports support from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the National Institute on Aging (NIA), National Institutes of Health (NIH) (R01 AG063391, R01 DK127961, R01 AG060756, K24 AG069080, and P30 DK092949). M.H.S. is also supported by R01 DK127961. P.R.C. is supported by grants from the NIH (R01 DK114098 and UL1 TR002541) and the Department of Veterans Affairs, Health Services Research, and Development (I01 HX003527). A.R.K. is supported by the National Center for Advancing Translational Sciences, NIH, through grant KL2TR002490. A.R.K. also reports receiving research grants from the Diabetes Research Connection and the ADA as well as a prize from the National Academy of Medicine outside the submitted work. R.E.P. reports support from the NIH (U01 DK127392, R01 DK122603, U01 DK135131, and DP3DK113358).



This document is currently not available here.

Peer Reviewed

Find in your library